Back to search results

Epco, Zanu, Ritux for R/R FL or MZL

Abroad (travel likely)RecruitingPHASE2

Conditions

Follicular Lymphoma · Lymphoma · Non-Hodgkin Lymphoma · Relapsed Lymphoma · Refractory Lymphoma · Marginal Zone Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Reid Merryman, MD) · Reid_merryman@dfci.harvard.edu · 617-632-6844
    Contact: Principal Investigator (Reid Merryman, MD)

  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Paola Ghione, MD) · ghionep@mskcc.org
    Contact: Principal Investigator (Paola Ghione, MD)

  • The Ohio State University Wexner Medical Center, Columbus, Ohio, United States

    Contact: Study coordinator (Aubree Shoemaker) · Aubree.Shoemaker@osumc.edu
    Contact: Principal Investigator (Yazeed Sawalha, MD)
Study leads

  • Reid Merryman, MD

    Principal Investigator

    Dana-Farber Cancer Institute

View source on ClinicalTrials.gov(opens in a new tab)